SEPARATION AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. Dated as of January 31, 2017Separation Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
This SEPARATION AGREEMENT (this “Agreement”), dated as of January 31, 2017, is entered into by and between Biogen Inc. (“Biogen”), a Delaware corporation, and Bioverativ Inc. (“Bioverativ”), a Delaware corporation and a wholly owned subsidiary of Biogen. “Party” or “Parties” means Biogen or Bioverativ, individually or collectively, as the case may be. Each capitalized term used and not elsewhere defined herein has the meaning set forth in Section 1.1.
TAX MATTERS AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. DATED AS OF JANUARY 31, 2017Tax Matters Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
This TAX MATTERS AGREEMENT (this “Agreement”) is entered into as of January 31, 2017, by and between Biogen Inc. (“Biogen”), a Delaware corporation, and Bioverativ Inc. (“Bioverativ”), a Delaware corporation and a wholly owned Subsidiary of Biogen. (Biogen and Bioverativ are sometimes collectively referred to herein as the “Parties” and, as the context requires, individually referred to herein as a “Party”).
EMPLOYEE MATTERS AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. Dated as of January 31, 2017Employee Matters Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
TRANSITION SERVICES AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. Dated as of February 1, 2017Transition Services Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC. Dated as of February 1, 2017Intellectual Property License Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
This INTELLECTUAL PROPERTY LICENSE AGREEMENT (this “Agreement”) is made and effective as of February 1, 2017 (the “Effective Date”) by and between Bioverativ Inc. (“Bioverativ”), a Delaware corporation, and Biogen Inc. (“Biogen”), a Delaware corporation (each of Bioverativ and Biogen being a “Party,” and collectively, the “Parties”).
MANUFACTURING AND SUPPLY AGREEMENT by and between BIOGEN INC. and BIOVERATIV INC. Dated as of January 31, 2017Manufacturing Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware
This Manufacturing and Supply Agreement (the “Agreement”) is made and entered into as of January 31, 2017, by and between Biogen Inc., a Delaware corporation (“Biogen”), and Bioverativ Inc., a Delaware corporation (“Bioverativ”). Each of the parties hereto are referred to collectively as the “Parties” and individually as a “Party”.
